Genoimmune
Latest round
- Series A
Last raised
- Dec 2020
Total raised
- $33M
Investors
- 3
About Genoimmune
Established in 2017 and based in Wuhan, China, Genoimmune operates as a cancer therapy developer that focuses on the research of tumor genomics, bioinformatics and tumor immunity.
Who invested in Genoimmune
3 investors across 2 rounds
See all investors in Genoimmune
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Genoimmune
Who invested in Genoimmune?
Genoimmune has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Genoimmune raised?
Genoimmune has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Genoimmune last raise money?
Genoimmune's most recent round on record is a Series A, in Dec 2020.
What does Genoimmune do?
Established in 2017 and based in Wuhan, China, Genoimmune operates as a cancer therapy developer that focuses on the research of tumor genomics, bioinformatics and tumor immunity.
Where is Genoimmune headquartered?
Genoimmune is headquartered in Wuhan, China.
Which VCs invest in companies like Genoimmune?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Genoimmune's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Genoimmune? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.